Vaxxas (VAXXAS AU)

The company develops a needle-free vaccine delivery system designed to enhance the performance of existing and next-generation vaccines. Its technology utilizes an array of vaccine-coated microprojections that perforate the outer layers of the skin to deposit vaccines directly among immune cells. The firm serves the healthcare and biotechnology sectors.